KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:待检查 入排置信度 0.98

QuantiFERON-TB supernatant-based biomarkers predicting active tuberculosis progression.

Haoxin Xu, Jingyu Zhou, Qingluan Yang, Yixuan Yang, Feiran Zhou, Mengqing Qian, Xing Lin, Wenhong Zhang, Lingyun Shao, Qiaoling Ruan

Int J Infect Dis 157 107915

PMID40320069
PMCID-
DOI10.1016/j.ijid.2025.107915
发表日期2025-05-04
入排依据:未发现恶性肿瘤人群证据。
入排复审未纳入:未发现恶性肿瘤人群证据。
摘要

摘要

BACKGROUND: Despite the higher specificity and reliability of detecting latent tuberculosis (TB) infection, Mycobacterium tuberculosis-specific interferon (IFN)-γ release assays do not perform satisfactorily in predicting the risk of active TB (ATB) development. It is crucial to identify new biomarkers with high predictive accuracy to identify individuals bearing a high risk of progression. METHODS: This was a sub-study of an open-label, randomized clinical trial for prevention of TB in silicosis patients. Twenty-six participants were diagnosed with ATB within 37-month' follow-up. They were defined as TB progressors and matched in a 1:2 ratio with 52 TB nonprogressors. RESULTS: We analyzed expression of 45 cytokines in QuantiFERON supernatants from TB progressors and nonprogressors, and granulocyte-macrophage colony-stimulating factor, vascular endothelial growth factor, interleukin (IL)-3, IFN-γ-induced protein 10, IL-10, and IL-9 outperformed IFN-γ as predictive markers. CONCLUSION: These findings highlight the potential of new biomarkers in identifying individuals with high risk of TB to undergo early intervention. TRIAL REGISTRATION: ClinicalTrials.gov number: NCT02430259.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。